Crossmark

Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity

Crossref DOI link: https://doi.org/10.1186/s13019-019-0856-4

Published Online: 2019-02-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aravot, Dan

Barac, Yaron D.

Krutzwald-Josefson, Efrat

Allen, Aaron M.

Flex, Dov

Peled, Nir

Kramer, Mordechai R.

Peysakhovich, Yuri

Saute, Milton
License Information

Text and Data Mining valid from 2019-02-12
More Information

Article History

Received: 5 February 2019

Accepted: 5 February 2019

First Online: 12 February 2019